XML 69 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Other Comprehensive Loss (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Consolidated Statements of Other Comprehensive Loss [Abstract]        
Net loss $ (74,221) $ (31,408) $ (173,261) $ (68,732)
Unrealized gains on investments 7 158 1,335 252
Comprehensive net loss attributable to Amylin Pharmaceuticals, Inc. shareholders $ (74,214) $ (31,250) $ (171,926) $ (68,480)